Sign up to our newsletter Subscribe
Learnings from the Assessments of Entrectinib and Larotrectinib: Health Technology Assessment Challenges Associated with Tumour-Agnostic Therapies
Policy, Organisation and Incentives in Health Systems
Health system policies should incentivise high-quality health care in areas of highest need at the lowest feasible cost. Our aim is to expand our understanding of policies that result in healthier populations and achieve sustainability while being responsive to patients’ needs.
A Critique of the Paper “The Estimated Costs of Production and Potential Prices for the World Health Organization Essential Medicines List”
